SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-023116
Filing Date
2020-08-20
Accepted
2020-08-20 16:48:58
Documents
8
Period of Report
2020-08-20

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea125846-6k_therapixbio.htm 6-K 12449
2 NOTICE AND PROXY STATEMENT FOR THE SPECIAL GENERAL MEETING TO BE HELD ON SEPTEMB ea125846ex99-1_therapix.htm EX-99.1 307304
3 PROXY CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON SEPTEMBER 10, 2020 ea125846ex99-2_therapix.htm EX-99.2 9549
4 VOTING INSTRUCTION CARD FOR THE SPECIAL GENERAL MEETING TO BE HELD ON SEPTEMBER ea125846ex99-3_therapix.htm EX-99.3 1397
5 GRAPHIC ex99-1_001.jpg GRAPHIC 3332
6 GRAPHIC ex99-2_001.jpg GRAPHIC 3332
7 GRAPHIC ex99-3_001.jpg GRAPHIC 173265
8 GRAPHIC ex99-3_002.jpg GRAPHIC 153621
  Complete submission text file 0001213900-20-023116.txt   705669
Mailing Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047
Business Address 4 ARIEL SHARON STREET HASHAHAR TOWER, 16TH FLOOR GIV?ATAYIM L3 5320047 972-3-6167055
Therapix Biosciences Ltd. (Filer) CIK: 0001611746 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38041 | Film No.: 201120571
SIC: 2834 Pharmaceutical Preparations